瘤细胞免疫性质的可塑性:它可以用药吗?
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA glenn_dranoff@dfci.harvard.edu.
Journal for immunotherapy of cancer
|April 24, 2025
概括
这种观点提供了关于癌症免疫治疗的见解,基于领先研究机构的经验. 它讨论了癌症治疗领域的观察和未来的猜测.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物医学研究生物医学研究
背景情况:
- 癌症免疫疗法代表了瘤治疗的重大进步.
- 达纳-法伯癌症研究所和诺华生物医学研究所的经验为当前的理解提供了信息.
研究的目的:
- 提出有关癌症免疫治疗的高级观察结果.
- 提供有关癌症免疫治疗未来的猜测.
主要方法:
- 对机构经验的基于视角的审查.
- 观察的综合和投机的见解的制定.
主要成果:
- 关于癌症免疫疗法的进展和挑战的关键观察.
- 关于免疫治疗方法不断变化的前景的投机性展望.
结论:
- 癌症免疫疗法继续发展,由持续的研究和临床经验驱动.
- 癌症免疫治疗的未来方向是由经验数据和前性假设构成的.
相关概念视频
Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer Stem Cells and Tumor Maintenance
4.6K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.6K
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K


